CI-994

Catalog #
27021
$155 *
Size: 50 mg
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

CI-994 is a histone deacetylase (HDAC) inhibitor that induces histone hyperacetylation. CI-994 inhibited HDAC-1 and HDAC-2 but not GCN5. CI-994 is also a novel antitumor agent, exhibiting activity against pancreatic, colon and mammary tumors. CI-994 inhibited the growth of two non-small cell lung cancer cell lines, A-549 (adenocarcinoma) and LX-1 (squamous cell carcinoma), with an IC50 of 80 µM.

This product has been cited 2 times.

Synonyms
Acetyldinaline, Gö 5549, PD 123654, Tacedinaline
Product Info
Storage and Usage
Citations2
Purity

≥99%

Format
White to off-white powder
Formula
C15H15N3O2
MW
269.3 Da
Solubility
Soluble in DMSO at 66 mg/ml; very poorly soluble in ethanol; very poorly soluble in water; maximum solubility in plain water is estimated to be about 25-100 µM; buffers, serum, or other additives may increase or decrease the aqueous solubility.
CAS Registry #
112522-64-2
References
1. Kraker, A.J., et al. Mol. Cancer Ther. 2: 401-408 (2003).
2. LoRusso, P.M., et al. Invest. New Drugs 14: 349-356 (1996).
3. Loprevite, M., et al. Oncol. Res. 15: 39-48 (2005).